Indian stocks: Visit www.stage2stocks.com →

Quanterix Corporation

Stage 4 · Declining · week 8

As of Oct 22, 2026, Quanterix is in Stage 4, the downtrend phase, now in week 8 (since Aug 31, 2026). It closed at $2.84, 64.8% below its 52-week high and below its 200-day average, which is falling.

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. More about the company

$2.84
+1.79% today
$134M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is QTRX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 29w
S4 30w
S4 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 10w → S3 9w → S2 12w → S3 4w → S4 29w → S1 4w → S4 30w → S1 8w → S4 8w → S1 6w → S2 11w → S3 5w → S4 14w → S1 8w → S4 8w current
Total tracked: 166 weeks across 15 stage runs.

QTRX among Medical Devices93rd of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…93QTRXStage 4 · wk 822−10.1%
vs 52W High
-64.8%
$2.42 lo$8.06 hi
64.8% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 8
1w13w26w
Week 8, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-28.9%
200 DMA: $4.00 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.67x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
→
Short-term trend flat
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-10.1%
3M
-22.6%
6M
-10.1%
YTD
-55.8%
1Y
-53.1%
Scan Membership
Breakout Watch
Latest: 2023-12-28
9 appearances in last 60 days. First seen: 2018-11-02.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 8 · Vol 0.67x
2026-10-21S4
Wk 8 · Vol 0.60x
2026-10-20S4
Wk 8 · Vol 0.64x
2026-10-19S4
Wk 7 · Vol 0.51x
2026-10-16S4
Wk 7 · Vol 0.38x
2026-10-15S4
Wk 7 · Vol 0.35x
2026-10-14S4
Wk 7 · Vol 0.41x
2026-10-13S4
Wk 7 · Vol 0.90x
2026-10-12S4
Wk 6 · Vol 0.67x
2026-10-09S4
Wk 6 · Vol 0.34x
2026-10-08S4
Wk 6 · Vol 0.73x
2026-10-07S4
Wk 6 · Vol 0.59x
Moving averages & range
50 DMA
$2.98
200 DMA
$4.00
52W High
$8.06
52W Low
$2.42
5D Low
$2.72
Resistance levels (recent highs)
20d High
$3.81
60d High
$4.03
120d High
$4.54
250d High
$8.06
Next resistance
+34.2%
to 20d High
ROE
-46.5%
Profit margin -80.2%
Dividend Yield
0.00%
P/B 0.6

Quanterix: quick answers

What stage is Quanterix in?

As of Oct 22, 2026, Quanterix (QTRX) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 31, 2026 and is in week 8. What the four stages mean

Is Quanterix in an uptrend?

No. Quanterix is in a Stage 4 downtrend. It trades 28.9% below its 200-day average, which is falling.

How far is Quanterix from its 52-week high?

Quanterix closed at $2.84 on Oct 22, 2026, 64.8% below its 52-week high of $8.06. Its 52-week low is $2.42.

How has Quanterix performed over the past year?

As of Oct 22, 2026, Quanterix is down 53.1% over the past year and down 55.8% so far in 2026.

Which sector and industry is Quanterix in?

Quanterix is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.